- call +1-201-465-4211
- email sales@mrinsights.biz
Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer.
Scope of the Report:
This report focuses on the Liposomes in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America dominated the market with market share of 44.2% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12.85%.
The worldwide market for Liposomes is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Other
Market Segment by Applications, can be divided into
Fungal Infection Therapy
Cancer & Tumor Therapy
Other
There are 15 Chapters to deeply display the global Liposomes market.
Chapter 1, to describe Liposomes Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Liposomes, with sales, revenue, and price of Liposomes, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Liposomes, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Liposomes market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Liposomes sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Liposomes Introduction
1.2 Market Analysis by Type
1.2.1 Liposomal Doxorubicin
1.2.2 Liposomal Amphoteracin B
1.2.3 Liposomal Paclitaxel
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Fungal Infection Therapy
1.3.2 Cancer & Tumor Therapy
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Business Overview
2.1.2 Liposomes Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Johnson & Johnson Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Gilead Sciences
2.2.1 Business Overview
2.2.2 Liposomes Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Gilead Sciences Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pacira
2.3.1 Business Overview
2.3.2 Liposomes Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pacira Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sun Pharmaceutical
2.4.1 Business Overview
2.4.2 Liposomes Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sun Pharmaceutical Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Luye Pharma
2.5.1 Business Overview
2.5.2 Liposomes Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Luye Pharma Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sigma-Tau Group
2.6.1 Business Overview
2.6.2 Liposomes Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sigma-Tau Group Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Fudan-Zhangjiang
2.7.1 Business Overview
2.7.2 Liposomes Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Fudan-Zhangjiang Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Teva Pharmaceutical
2.8.1 Business Overview
2.8.2 Liposomes Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Pharmaceutical Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 CSPC
2.9.1 Business Overview
2.9.2 Liposomes Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 CSPC Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Novartis
2.10.1 Business Overview
2.10.2 Liposomes Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novartis Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Kingond Pharm
2.11.1 Business Overview
2.11.2 Liposomes Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Kingond Pharm Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Spectrum Pharmaceuticals
2.12.1 Business Overview
2.12.2 Liposomes Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Spectrum Pharmaceuticals Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Shanghai New Asia
2.13.1 Business Overview
2.13.2 Liposomes Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Shanghai New Asia Liposomes Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Liposomes Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Liposomes Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Liposomes Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Liposomes Manufacturer Market Share in 2017
3.3.2 Top 6 Liposomes Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Liposomes Market Analysis by Regions
4.1 Global Liposomes Sales, Revenue and Market Share by Regions
4.1.1 Global Liposomes Sales and Market Share by Regions (2013-2018)
4.1.2 Global Liposomes Revenue and Market Share by Regions (2013-2018)
4.2 North America Liposomes Sales and Growth Rate (2013-2018)
4.3 Europe Liposomes Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Liposomes Sales and Growth Rate (2013-2018)
4.5 South America Liposomes Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Liposomes Sales and Growth Rate (2013-2018)
5 North America Liposomes by Countries
5.1 North America Liposomes Sales, Revenue and Market Share by Countries
5.1.1 North America Liposomes Sales and Market Share by Countries (2013-2018)
5.1.2 North America Liposomes Revenue and Market Share by Countries (2013-2018)
5.2 United States Liposomes Sales and Growth Rate (2013-2018)
5.3 Canada Liposomes Sales and Growth Rate (2013-2018)
5.4 Mexico Liposomes Sales and Growth Rate (2013-2018)
6 Europe Liposomes by Countries
6.1 Europe Liposomes Sales, Revenue and Market Share by Countries
6.1.1 Europe Liposomes Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Liposomes Revenue and Market Share by Countries (2013-2018)
6.2 Germany Liposomes Sales and Growth Rate (2013-2018)
6.3 UK Liposomes Sales and Growth Rate (2013-2018)
6.4 France Liposomes Sales and Growth Rate (2013-2018)
6.5 Russia Liposomes Sales and Growth Rate (2013-2018)
6.6 Italy Liposomes Sales and Growth Rate (2013-2018)
7 Asia-Pacific Liposomes by Countries
7.1 Asia-Pacific Liposomes Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Liposomes Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Liposomes Revenue and Market Share by Countries (2013-2018)
7.2 China Liposomes Sales and Growth Rate (2013-2018)
7.3 Japan Liposomes Sales and Growth Rate (2013-2018)
7.4 Korea Liposomes Sales and Growth Rate (2013-2018)
7.5 India Liposomes Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Liposomes Sales and Growth Rate (2013-2018)
8 South America Liposomes by Countries
8.1 South America Liposomes Sales, Revenue and Market Share by Countries
8.1.1 South America Liposomes Sales and Market Share by Countries (2013-2018)
8.1.2 South America Liposomes Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Liposomes Sales and Growth Rate (2013-2018)
8.3 Argentina Liposomes Sales and Growth Rate (2013-2018)
8.4 Colombia Liposomes Sales and Growth Rate (2013-2018)
9 Middle East and Africa Liposomes by Countries
9.1 Middle East and Africa Liposomes Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Liposomes Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Liposomes Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Liposomes Sales and Growth Rate (2013-2018)
9.3 UAE Liposomes Sales and Growth Rate (2013-2018)
9.4 Egypt Liposomes Sales and Growth Rate (2013-2018)
9.5 Nigeria Liposomes Sales and Growth Rate (2013-2018)
9.6 South Africa Liposomes Sales and Growth Rate (2013-2018)
10 Global Liposomes Market Segment by Type
10.1 Global Liposomes Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Liposomes Sales and Market Share by Type (2013-2018)
10.1.2 Global Liposomes Revenue and Market Share by Type (2013-2018)
10.2 Liposomal Doxorubicin Sales Growth and Price
10.2.1 Global Liposomal Doxorubicin Sales Growth (2013-2018)
10.2.2 Global Liposomal Doxorubicin Price (2013-2018)
10.3 Liposomal Amphoteracin B Sales Growth and Price
10.3.1 Global Liposomal Amphoteracin B Sales Growth (2013-2018)
10.3.2 Global Liposomal Amphoteracin B Price (2013-2018)
10.4 Liposomal Paclitaxel Sales Growth and Price
10.4.1 Global Liposomal Paclitaxel Sales Growth (2013-2018)
10.4.2 Global Liposomal Paclitaxel Price (2013-2018)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2013-2018)
10.5.2 Global Other Price (2013-2018)
11 Global Liposomes Market Segment by Application
11.1 Global Liposomes Sales Market Share by Application (2013-2018)
11.2 Fungal Infection Therapy Sales Growth (2013-2018)
11.3 Cancer & Tumor Therapy Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Liposomes Market Forecast (2018-2023)
12.1 Global Liposomes Sales, Revenue and Growth Rate (2018-2023)
12.2 Liposomes Market Forecast by Regions (2018-2023)
12.2.1 North America Liposomes Market Forecast (2018-2023)
12.2.2 Europe Liposomes Market Forecast (2018-2023)
12.2.3 Asia-Pacific Liposomes Market Forecast (2018-2023)
12.2.4 South America Liposomes Market Forecast (2018-2023)
12.2.5 Middle East and Africa Liposomes Market Forecast (2018-2023)
12.3 Liposomes Market Forecast by Type (2018-2023)
12.3.1 Global Liposomes Sales Forecast by Type (2018-2023)
12.3.2 Global Liposomes Market Share Forecast by Type (2018-2023)
12.4 Liposomes Market Forecast by Application (2018-2023)
12.4.1 Global Liposomes Sales Forecast by Application (2018-2023)
12.4.2 Global Liposomes Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Liposomes Picture
Table Product Specifications of Liposomes
Figure Global Sales Market Share of Liposomes by Types in 2017
Table Liposomes Types for Maj
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
